Page 382 - PROGRAMME2018

PRODUCT THEATRES – ROOM 129
Monday, 2 July 2018:
09:15 - 10:15 Thermo Fisher Scientific Thermo Fisher Scientific and Technology intro:
• Reproductive healthcare: analytical performance of a high-throughput genotyping approach for comprehensive preconception carrier screening
Julio Martín (Igenomix)
• Embryo aneuploidy testing by NGS Carmen Rubio (Igenomix)
• Improving PGT through PGD-Seq and Ion Reproseq PGS Kit Luis Alcaraz (Bioarray)
10:30 - 11:30 ObsEva
Nolasiban – A New Oral Oxytocin Receptor Antagonist to Increase Live Birth Rates Following Fresh Embryo Transfer
Resulting from In Vitro Fertilization (IVF)
Chair: Ben Willem Mol Co-chair: Ernest Loumaye
• Oxytocin Receptor Antagonists and Uterine Receptivity:
Physiological Background and Potential Mechanism of Action
Speaker: Lan N. Vuong, MD, PhD - University of Medicine and Pharmacy at Ho Chi Minh City, Viet Nam
• Clinical Evidence for Nolasiban to Increase Pregnancy and Live Birth Rates: Results of
Two Large Placebo Controlled Randomized Trials
Speaker: Christophe Blockeel, MD, PhD - Centre for Reproductive Medicine, Free University of Brussels, Belgium
• Nolasiban as a Catalyst for Elective Single Embryo Transfer (eSET) Speaker: Ben Willem Mol, FRANZCOG, PhD
Department of Obstetrics and Gynaecology, Monash University, Australia
• Conclusions - Q&A
17:45 - 18:45 Aytu BioScience
“Male Infertility: Understanding the Role and Implications of Oxidative Stress”
Speakers: Ashok Agarwal, Ph.D.
Professor of Surgery (Urology), Director of Andrology Center.
Lerner College of Medicine, Case Western Reserve University and Cleveland Clinic
Moncef Benkhalifa, Ph.D.
Clinical Embryologist & Professor of Medicine. Picardie University. Jules Verne. France
382